Counselors in Red Oak, IA Accepting Medicare

8 Counselors found. Showing 1 - 8

Alexandra Jordan Inselman, PLMHP Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 706 W 2nd St, Red Oak, IA 51566 Phone: 402-616-9876    Fax: 712-355-5120

Ms. Delaina Nicole Lindensmith Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 1977 G Avenue, Red Oak, IA 51566 Phone: 712-623-6349    Fax: 712-623-6047

Emily Herzberg Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1101 E Summit St Ste 2, Red Oak, IA 51566 Phone: 712-210-0840

Etta Murphy, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1101 Summit St. Ste. 2, Red Oak, IA 51566 Phone: 712-520-0237

Jason David Swain, TLMHC, PLMHP Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 1000 N Broadway St, Red Oak, IA 51566 Phone: 712-581-7900

Ms. Crystal Michele Sharp, LIMHP, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 706 W 2nd Street, Red Oak, IA 51566 Phone: 402-616-9876    Fax: 712-355-5120

Michael J Mcgargill, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1101 E Summit St Ste 2, Red Oak, IA 51566 Phone: 712-370-6846    Fax: 866-675-5954

Ann Marie Ross, TEMPARARY LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1308 State Highway 48, Red Oak, IA 51566 Phone: 712-370-4578

News Archive

Largest study ever to look at possible heart risks with ADHD medications

Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.

KYTHERA initiates proof-of-concept trial of its ATX-104 light-activated facial contouring agent

KYTHERA Biopharmaceuticals, Inc. (KYTHERA) today announced that it has initiated a first-in-human, proof-of-concept study evaluating the safety, tolerability, persistence and histological effects of ATX-104, a light-activated facial contouring agent.

DARA's KRN5500 meets primary end-points in Phase II study for chemotherapy-induced neuropathic pain

Thanks to greater awareness, earlier detection and improving therapeutic agents, people with cancer are living longer than ever before. One of the consequences of living longer is the symptom burden of cancer survivorship, which may have a substantial impact on quality of life for many survivors. One such burden is the pain syndromes resulting from cancer treatments.

CAMY study shows youth exposure to alcohol advertising in magazines decline by 48%

Youth exposure to alcohol advertising in magazines declined by 48 percent between 2001 and 2008, according to a new study by the Center on Alcohol Marketing and Youth at the Johns Hopkins Bloomberg School of Public Health.

Loyola employee donates kidney to complete stranger, saves her own life

When Dorothy Jambrosek, 47, decided to donate a kidney to a stranger, she didn't realize that her goodwill would save her own life. After undergoing a series of tests required to give a kidney, doctors discovered that Jambrosek had precancerous lesions in her breast that could become cancerous.

Read more Medical News

› Verified 7 days ago